Heikki Julkunen

4.8k citations
88 papers · 2.6k indexed · h-index 29

Heikki Julkunen

83 papers receiving 2.5k citations

Peers

Heikki Julkunen
Comparison fields: 5 of 93
  • Rheumatology 1.8k
  • Immunology 1.1k
  • Hematology 327
  • Nephrology 152
  • Immunology and Allergy 114
Replace M L Boey with:
M L Boey Singapore
Javier Cabiedes Mexico
A. J. G. Swaak Netherlands
J. D. Reveille United States
Anca Askanase United States
Maria Gerosa Italy
G. Dennis United States
Maria Grazia Sabbadini Italy
Alberto Cauli Italy
R. H. W. M. Derksen Netherlands
Heikki Julkunen relative to M L Boey Singapore M L Boey's profile →
Citations per field
00.5×
M L Boey · 1×
Citations per year

Countries citing papers authored by Heikki Julkunen

Since Specialization
Citations

This map shows the geographic impact of Heikki Julkunen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heikki Julkunen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heikki Julkunen more than expected).

Fields of papers citing papers by Heikki Julkunen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heikki Julkunen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heikki Julkunen. The network helps show where Heikki Julkunen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Heikki Julkunen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Heikki Julkunen Line = papers co-authored together Heikki Julkunen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20136
2 201324
3 200941
4 200916
5 200563
6 2005453
7 200418
8 2004144
9 200338
10 200142
11 20008
12 19991
13 199812
14 199832
15 199356
16 199119
17 199171
18 19904
19 198823
20
[Prevention of venous thromboemboli with low doses of heparin in patients with proximal femur fractures].
19801

About Heikki Julkunen

Heikki Julkunen is a scholar working on Rheumatology, Immunology and Nephrology, having authored 88 papers that have together received 2.6k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (63 papers), Rheumatoid Arthritis Research and Therapies (17 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), T-cell and B-cell Immunology (9 papers), Immunodeficiency and Autoimmune Disorders (8 papers), Blood disorders and treatments (7 papers), Diabetes and associated disorders (7 papers) and Systemic Sclerosis and Related Diseases (6 papers). The work is most often cited by research in Rheumatology (1.8k citations), Immunology (1.1k citations) and Hematology (327 citations). Heikki Julkunen has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Risto Kaaja, Marjatta Leirisalo‐Repo, Juha Kere, Sari Koskenmies, M. Eronen, Claes Friman, Hannu Kautiainen, Pekka Kurki, Marja‐Kaisa Siren and Aaro Miettinen. Their work appears in journals such as PLoS ONE, PEDIATRICS and The American Journal of Human Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026